C37H48N6O5S2
Neat
720.95
1414933-82-6; Ritonavir EP Impurity Q; Thiazol-5-ylmethyl (2S, 3R, 5R)-3-hydroxy-5-((S)-2-(3-((2-isopropylthiazol-4-yl)methyl)-3-methylureido(-3-methylbutanamido)-1, 6-diphenylhexan-2-ylcarbamate; 2TJ3KVE30D; 1, 3-thiazol-5-ylmethyl N-[(2S, 3R, 5R)-3-hydroxy-5-[[(2S)-3-methyl-2-[[methyl-[(2-propan-2-yl-1, 3-thiazol-4-yl)methyl]carbamoyl]amino]butanoyl]amino]-1, 6-diphenylhexan-2-yl]carbamate; 2, 7, 10, 12-Tetraazatridecanoic acid, 4-hydroxy-12-methyl-9-(1-methylethyl)-13-(2-(1-methylethyl)-4-thiazolyl)-8, 11-dioxo-3, 6-bis(phenylmethyl)-, 5-thiazolylmethyl ester, (3S, 4R, 6R, 9S)-; Thiazol-5-ylmethyl ((1S, 2R, 4R)-1-benzyl-2-hydroxy-4-(((2S)-3-methyl-2-((methyl((2-(1-methylethyl)thiazol-4-yl)methyl)carbamoyl)amino)butanoyl)amino)-5-phenylpentyl)carbamate; Thiazol-5-ylmethyl ((2S, 3R, 5R)-3-hydroxy-5-((S)-2-(3-((2-isopropylthiazol-4-yl)methyl)-3-methylureido)-3-methylbutanamido)-1, 6-diphenylhexan-2-yl)carbamate; UNII-2TJ3KVE30D; Ritonavir impurity Q [EP]; Ritonavir impurity, 3R, 5R-diastereomer- [USP]; RITONAVIR IMPURITY Q [EP IMPURITY]; Q27255584; RITONAVIR IMPURITY, 3R and 5R-DIASTEREOMER- [USP IMPURITY]
1, 3-thiazol-5-ylmethyl N-[(2S, 3R, 5R)-3-hydroxy-5-[[(2S)-3-methyl-2-[[methyl-[(2-propan-2-yl-1, 3-thiazol-4-yl)methyl]carbamoyl]amino]butanoyl]amino]-1 and 6-diphenylhexan-2-yl]carbamate
InChI=1S/C37H48N6O5S2/c1-24(2)33(42-36(46)43(5)20-29-22-49-35(40-29)25(3)4)34(45)39-28(16-26-12-8-6-9-13-26)18-32(44)31(17-27-14-10-7-11-15-27)41-37(47)48-21-30-19-38-23-50-30/h6-15,19,22-25,28,31-33,44H,16-18,20-21H2,1-5H3,(H,39,45)(H,41,47)(H,42,46)/t28-,31+,32-,33+/m1/s1